
Bradykinin 1 Receptor Antagonist BI1026706 Does Not Reduce Central Retinal Thickness in Center-Involved Diabetic Macular Edema
Author(s) -
Gabriele E. Lang,
Ramin Tadayoni,
Wenbo Tang,
Cláudia Barth,
Cornelia Weiss-Haljiti,
Victor Chong
Publication year - 2020
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.9.4.25
Subject(s) - medicine , peripheral edema , tolerability , placebo , macular edema , retinal , diabetic retinopathy , pharmacodynamics , adverse effect , ophthalmology , diabetes mellitus , endocrinology , pharmacokinetics , pathology , alternative medicine